Top compounds associated with response to LYRM5


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.019 0.6
mRNA tosedostat CTRPv2 pan-cancer AAC 0.0017 1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.00083 1
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.021 0.5
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.0077 0.8
mRNA triptolide CTRPv2 pan-cancer AAC -0.04 0.2
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.042 0.4
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.012 0.7
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.03 0.4
Download CSV